Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swaroop Kumar Pandey

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Current Drug Metabolism|July 10, 2024
Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and OpportunitiesSwaroop Kumar Pandey, Sona Verma, Shobha Upreti, et al.
Biomolecules|July 27, 2022
Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor HallmarksSwaroop Kumar Pandey, Renen Machlof-Cohen, Manikandan Santhanam, et al.
Cancers|March 11, 2023
Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic ExtractAlmog Nadir, Anna Shteinfer-Kuzmine, Swaroop Kumar Pandey, et al.
Current Molecular Medicine|September 25, 2024
Stem Cells as a Novel Source for Regenerative Medicinal Applications in Alzheimer's Disease: An UpdateKratika Pandey, Priyanka Srivastava, Swaroop Kumar Pandey, et al.
Molecular Oncology|April 1, 2021
SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesisSwaroop Kumar Pandey, Avijit Paul, Anna Shteinfer-Kuzmine, et al.
Parasitology|June 28, 2019
Potential role of arteether on N-methyl-D-aspartate (NMDA) receptor expression in experimental cerebral malaria mice and extension of their survivalSunil Kumar Singh, Hemlata Dwivedi, Sarika Gunjan, et al.
Bioorganic & Medicinal Chemistry|December 20, 2008
Organocatalyzed highly atom economic one pot synthesis of tetrahydropyridines as antimalarialsMridul Misra, Swaroop Kumar Pandey, Vivek Parashar Pandey, et al.
Cells|October 15, 2024
Correction: Pittala et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. <i>Cells</i> 2020, <i>9</i>, 481Srinivas Pittala, Idan Levy, Soumasree De, et al.
Cells|February 26, 2020
The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes MellitusSrinivas Pittala, Idan Levy, Soumasree De, et al.
Life (Basel, Switzerland)|December 23, 2022
Naringin Attenuates the Diabetic Neuropathy in STZ-Induced Type 2 Diabetic Wistar RatsMd Fahim Ahmad, Nida Naseem, Inamur Rahman, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Current Drug Metabolism|July 10, 2024
Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and OpportunitiesSwaroop Kumar Pandey, Sona Verma, Shobha Upreti, et al.
Biomolecules|July 27, 2022
Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor HallmarksSwaroop Kumar Pandey, Renen Machlof-Cohen, Manikandan Santhanam, et al.
Cancers|March 11, 2023
Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic ExtractAlmog Nadir, Anna Shteinfer-Kuzmine, Swaroop Kumar Pandey, et al.
Current Molecular Medicine|September 25, 2024
Stem Cells as a Novel Source for Regenerative Medicinal Applications in Alzheimer's Disease: An UpdateKratika Pandey, Priyanka Srivastava, Swaroop Kumar Pandey, et al.
Molecular Oncology|April 1, 2021
SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesisSwaroop Kumar Pandey, Avijit Paul, Anna Shteinfer-Kuzmine, et al.
Parasitology|June 28, 2019
Potential role of arteether on N-methyl-D-aspartate (NMDA) receptor expression in experimental cerebral malaria mice and extension of their survivalSunil Kumar Singh, Hemlata Dwivedi, Sarika Gunjan, et al.
Bioorganic & Medicinal Chemistry|December 20, 2008
Organocatalyzed highly atom economic one pot synthesis of tetrahydropyridines as antimalarialsMridul Misra, Swaroop Kumar Pandey, Vivek Parashar Pandey, et al.
Cells|October 15, 2024
Correction: Pittala et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. <i>Cells</i> 2020, <i>9</i>, 481Srinivas Pittala, Idan Levy, Soumasree De, et al.
Cells|February 26, 2020
The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes MellitusSrinivas Pittala, Idan Levy, Soumasree De, et al.
Life (Basel, Switzerland)|December 23, 2022
Naringin Attenuates the Diabetic Neuropathy in STZ-Induced Type 2 Diabetic Wistar RatsMd Fahim Ahmad, Nida Naseem, Inamur Rahman, et al.
Pageof 4